📈 Will you get serious about investing in 2025? Take the first step with 50% off InvestingProClaim Offer

U.S. EXIM bank halts export finance support for medical equipment

Published 04/14/2020, 02:03 PM
Updated 04/14/2020, 02:40 PM

WASHINGTON (Reuters) - The U.S. Export-Import Bank of the United States said on Tuesday it was temporarily withdrawing all financing support for exports of critical medical equipment and supplies needed to fight the coronavirus, including respirators, face shields, gloves and other personal protective equipment.

The exclusion order, which will remain in place until Sept. 30, was unanimously approved by the export credit agency's board of directors "to help ensure the United States has medical supplies and equipment that are in short supply and necessary to combat and prevent the spread of the COVID-19 (coronavirus) pandemic in the United States," EXIM said in a statement.

It comes as President Donald Trump has sought to limit exports of critical medical supplies, including masks from 3M Co (N:MMM).

EXIM said the exclusion order applies to all of its loans, loan guarantees, and insurance products covering items identified in a March 25 notice https://www.hhs.gov/sites/default/files/hhs-dfa-notice-of-scarce-materials-for-hoarding-prevention.pdf from the Department of Health and Human Services and an April 3 memorandum https://www.whitehouse.gov/presidential-actions/memorandum-allocating-certain-scarce-threatened-health-medical-resources-domestic-use from Trump to allocate medical resources to domestic use.

These items include N95 respirators, other surgical masks, face shields, medical examination gloves, portable ventilators, powered air purifying respirators, medical gowns, sanitizing and sterilization and drugs containing hydroxychloroquine as their active ingredient.

EXIM President Kimberly Reed said financing of medical equipment exports is currently less than 1% of EXIM's overall financing portfolio.

The export lender, which was restricted to small transactions until last May by congressional inaction over board nominees, financed only about $9.1 billion of U.S. export sales in the fiscal year ended Sept. 30, 2019.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.